Axim Planning & Wealth’s APEX HealthCare ETF APXH Stock Holding History

Axim Planning & Wealth’s Portfolio APXH Stock Details APXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-242	Closed	-$2K	–	175
2022 Q2	$2K	Buy	+242	New	+$2.11K	﹤0.01%	126

Other funds holding APXH

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Axim Planning & Wealth's APXH Position: Q3 2022 in Review

Axim Planning & Wealth sold out of APEX HealthCare ETF (APXH) in Q3 2022, closing a stake of 242 shares — an estimated $2K sold.

Axim Planning & Wealth first reported a position in APXH in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 6 funds tracked by Wall St. Rank hold APXH as of Q3 2022.

Axim Planning & Wealth reported no remaining APEX HealthCare ETF position as of Q3 2022 after selling out during the quarter.
Axim Planning & Wealth sold 242 APEX HealthCare ETF shares in Q3 2022, an estimated $2K.
Axim Planning & Wealth first reported a position in APEX HealthCare ETF in Q2 2022 and held it in 1 quarter.
Axim Planning & Wealth's APEX HealthCare ETF position peaked at $2K in Q2 2022.
6 funds tracked by Wall St. Rank held APEX HealthCare ETF as of Q3 2022.

Based on Axim Planning & Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.